Hospice Services for Complicated Grief and Depression: Results from a National Survey.
Hospice Services for Complicated Grief and Depression: Results from a National Survey.
复制标题
DOI：
10.1111/jgs.13656
复制
发表时间：
2015-10
影响因子：
6.3
通讯作者：
Bradley E
中科院分区：
文献类型：
--
作者：
Ghesquiere AR;Aldridge MD;Johnson-Hürzeler R;Kaplan D;Bruce ML;Bradley E
描述在临终关怀中筛查复杂悲伤(CG)和抑郁的流行率以及获得丧亲治疗的机会，并检查筛查和获得治疗的机会是否因临终关怀的组织特征或工作人员的培训和参与而有所不同。2008年至2009年进行的横断面全国调查。美国。临终关怀机构(N=591)。临终关怀机构是否在死亡时对抑郁症或CG进行筛查，或提供丧亲治疗(个人或团体)。组织特征包括地区、连锁状态、所有权和患者数量。与人员配置相关的变量包括培训时长和出席率要求。55%的临终关怀院提供CG和抑郁症筛查，并提供丧亡之痛治疗；13%提供筛查但不提供丧亡之痛治疗；24%提供丧亲治疗但不提供筛查；8%既不筛查也不提供丧亡之痛治疗。每天有100名或更多患者的临终关怀机构更有可能提供筛查和丧亲治疗。临终关怀机构似乎有很高的能力为CG和抑郁症提供筛查，并提供小组和个人治疗，但需要数据来确定筛查者是否以证据为基础，以及治疗是否针对CG或抑郁症。未来的工作可以建立在现有基础设施的基础上，以确保使用经过充分验证的筛查和循证疗法。
To describe the prevalence of screening for complicated grief (CG) and depression in hospice and access to bereavement therapy and to examine whether screening and access to therapy varied according to hospice organizational characteristics or staff training and involvement. Cross-sectional national survey conducted from 2008 to 2009. United States. Hospices (N = 591). Whether hospices screened for depression or CG at the time of death or provided access to bereavement therapy (individual or group). Organizational characteristics included region, chain status, ownership, and patient volume. Staffing-related variables included training length and meeting attendance requirements. Fifty-five percent of hospices provided screening for CG and depression and access to bereavement therapy, 13% provided screening but not access to bereavement therapy, 24% provided access to bereavement therapy but not screening, and 8% neither screened nor provided access to bereavement therapy. Hospices with 100 patients per day or more were significantly more likely to provide screening and access to bereavement therapy. Hospices appear to have high capacity to provide screening for CG and depression and to deliver group and individual therapy, but data are needed on whether screeners are evidence based and whether therapy addresses CG or depression specifically. Future work could build upon existing infrastructure to ensure use of well-validated screeners and evidence-based therapies.